After a historic jury trial, two Chinese companies—Hebei Welcome Pharmaceutical Company Ltd. and North China Pharmaceutical Group Corp.—have been ordered to pay $162 million for fixing Vitamin C prices.

A federal jury in Brooklyn returned a $54 million verdict against the defendants on March 14. Eastern District Judge Brian Cogan (See Profile) awarded trebled damages to $162 million.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]